ID   NCC-MFS5-C1
AC   CVCL_B5YX
DR   Wikidata; Q112129415
RX   PubMed=35053323;
WW   Provider; BizCom; -; https://en.cellline.jp/product/ncc-mfs5-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 91.7 hours (PubMed=35053323).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35053323).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=35053323).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=35053323).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Right elbow, hypodermis; UBERON=UBERON_0001461+UBERON_0002072.
ST   Source(s): PubMed=35053323
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D21S11: 30,32
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 8
//
RX   PubMed=35053323; DOI=10.3390/cells11020207; PMCID=PMC8773631;
RA   Tsuchiya R., Yoshimatsu Y., Noguchi R., Sin Y., Ono T., Akiyama T.,
RA   Sugaya J., Kobayashi E., Kojima N., Yoshida A., Ohtori S., Kawai A.,
RA   Kondo T.;
RT   "Establishment and characterization of NCC-MFS5-C1: a novel
RT   patient-derived cell line of myxofibrosarcoma.";
RL   Cells 11:207.1-207.13(2022).
//